Is the Measurement of Cerebral Microembolic Signals a Good Surrogate Marker for Evaluating the Efficacy of Antiplatelet Agents in the Prevention of Stroke?

Publisher： Karger

E-ISSN： 1421-9913|53|3|132-139

ISSN： 0014-3022

Source： European Neurology, Vol.53, Iss.3, 2005-04, pp. : 132-139

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Antiplatelet Agents for Stroke Prevention

By  

Cerebrovascular Diseases, Vol. 10, Iss. 4, 2000-10 ,pp. : 36-39

Karger

Access to resources Recommend Favorite

Antiplatelet Agents in Stroke Prevention

By  

Cerebrovascular Diseases, Vol. 10, Iss. 5, 2004-11 ,pp. : 41-48

Karger

Access to resources Recommend Favorite

Efficacy of Dual Antiplatelet Therapy in Cerebrovascular Disease as Demonstrated by a Decline in Microembolic Signals

By  

Cerebrovascular Diseases, Vol. 21, Iss. 4, 2006-03 ,pp. : 242-246

Karger

Access to resources Recommend Favorite

The Significance of Microembolic Signals and New Cerebral Infarcts on the Progression of Neurological Deficit in Acute Stroke Patients with Large Artery Stenosis

By  

Cerebrovascular Diseases, Vol. 29, Iss. 5, 2010-03 ,pp. : 424-430

Karger

Access to resources Recommend Favorite

Secondary Prevention of Stroke with Antiplatelet Agents in Patients with Diabetes mellitus

By  

Cerebrovascular Diseases, Vol. 20, Iss. 1, 2005-11 ,pp. : 15-23

Karger

Access to resources Recommend Favorite